R332 (Pantoprazole sodium delayed release 20 mg)
Pill imprint R332 has been identified as Pantoprazole sodium delayed release 20 mg.
Pantoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; dumping syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for R332
- 20 mg
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 400
ferric oxide yellow
More about pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.